Search clinical trials for: Subcutaneous enoxaparin

Total 1081 results

Biocad

Completed

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Deep Vein Thrombosis

Russian Federation
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Radial Artery Occlusion

China
French Cardiology Society

Completed

Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

Renal Failure | Acute Coronary Syndrome

France
Centro Hospitalar de Lisboa Central
NOVA Medical School

Enrolling by invitation

LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth) (HepaGrowth)

Pre-Eclampsia | Fetal Growth Retardation | Prematurity

Portugal
Mashhad University of Medical Sciences

Unknown

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Esophageal Neoplasms

Iran, Islamic Republic of
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Pregnancy | Heart; Complications, Valve, Prosthesis

Turkey
Sanofi

Completed

HENOX: Enoxaparine in Hemodialysis

Hemodialysis

Thailand
Damian Ratano
PSI Foundation, Toronto, Ontario

Recruiting

Anticoagulation-free VV ECMO for Acute Respiratory Failure (A-FREE ECMO)

Extracorporeal Membrane Oxygenation Complication

Canada
Shaare Zedek Medical Center

Completed

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

Critical Illness | Venous Thrombosis

Israel
Assistance Publique - Hôpitaux de Paris

Suspended

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients (Childbenox)

Cirrhosis

France
University Hospital, Brest

Terminated

Prevention of Unexplained Recurrent Abortion by Enoxaparine (PREFIX)

Alive and Viable Births

France
Stealth BioTherapeutics Inc.

Completed

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA (ReCLAIM-2)

Age-related Macular Degeneration

United States
University of Colorado, Denver
Bristol-Myers Squibb

Completed

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Gynecologic Cancer | Venous Thromboembolism

United States
V.K.V. American Hospital, Istanbul

Completed

Low Molecular Weight Heparin in Recurrent Implantation Failure

Infertility | Recurrent Implantation Failure | Fertilization in Vitro

Turkey
Indonesia University
PT Metiska Farma

Completed

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Enoxaparin

Indonesia
Bayer

Completed

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Venous Thromboembolism

United States, Canada
Oregon Health and Science University
National Trauma Research Institute; Medical Research Foundation, Oregon

Completed

Thrombelastography Based Dosing of Enoxaparin

Thromboembolic Complications

United States
Tel-Aviv Sourasky Medical Center

Unknown

Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity

Obesity

Israel
University of Oulu
University of Helsinki

Unknown

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Intracerebral Hemorrhage

Finland
Peking Union Medical College Hospital

Completed

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) (OPTIENOX-PCI)

Coronary Artery Disease | Percutaneous Coronary Intervention

China
PT Bio Farma

Recruiting

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Safety Issues | Effect of Drug

Indonesia
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
University of Utah
University of Michigan

Completed

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Surgery | Venous Thromboembolism | Deep Venous Thrombosis

United States
Lebanese American University

Completed

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Renal Impairment | Venous Thromboembolism

Lebanon
Wake Forest University Health Sciences

Terminated

Clot Dissolving Treatment for Blood Clots in the Lungs

Pulmonary Embolism

United States
Chemi S.p.A.

Completed

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

Enoxaparin Sodium is Administered to Healthy Volunteers

United Kingdom
Oregon Health and Science University

Terminated

Below Knee DVT Study

Deep Vein Thrombosis (DVT) | Blood Clots

United States
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Venous Thromboembolism

Brazil
Beijing Friendship Hospital

Unknown

ESM Versus OM ：A Randomized Controlled Trial

Endoscopic Subcutaneous Mastectomy

China
University of Utah

Completed

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
Oregon Health and Science University

Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Trauma | Surgery | Deep Vein Thrombosis (DVT) | Thromboembolic Events

United States
Venus Remedies Limited

Completed

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Healthy

India
Rovi Pharmaceuticals Laboratories
PRA Health Sciences

Completed

Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

Healthy
Assistance Publique - Hôpitaux de Paris

Recruiting

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) (OPTI-TREX)

Pediatric Kidney Transplant Recipients

France
University of Cincinnati
United States Air Force

Completed

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

Venous Thromboembolism | Traumatic Injury

United States
Sanofi

Completed

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Venous Thromboembolism

France, Russian Federation, Spain, Italy, Argentina, Belgium, Brazil, Canada, Colombia, Germany, Israel, Mexico, Poland, United States, Australia, Austria, India, South Africa, United Kingdom, Tunisia
Sanofi

Completed

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

Myocardial Infarction | Acute ST-Segment Elevation

Canada, Brazil, Poland, Romania, Russian Federation, Ukraine, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Estonia, India, Malaysia, Singapore, Slovakia, Belgium, Mexico, Uruguay, Argentina, Croatia, Austr... and more
GlycoMimetics Incorporated
University of Michigan

Completed

Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Healthy Volunteers

United States
Hannover Medical School

Terminated

Taxotere-Enoxaparin-(ENOXA)-Study

Non-small Cell Lung Cancer

Germany
Columbia University

Completed

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 (IMPROVE)

COVID-19 | Venous Thromboses | Arterial Thrombosis

United States
Regado Biosciences, Inc.

Completed

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD (SC101)

Healthy Volunteer

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects

Healthy Subjects | Pharmacokinetics of ASP6294

United Kingdom
University of Utah
Agency for Healthcare Research and Quality (AHRQ)

Completed

Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
The Egyptian IVF-ET Center

Completed

Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)

Infertility

Egypt
University of Sao Paulo General Hospital

Completed

Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

Venous Thrombosis | Deep Vein Thrombosis | Pulmonary Embolism | Perioperative/Postoperative Complications | Thrombophilia Associated With Pregnancy | Other Specified Risk Factors in Pregnancy

Brazil
The University of The West Indies

Not yet recruiting

To Investigate the Effect of Continuous Versus Interrupted Subcutaneous Fat Closure in Reducing Surgical Site Infection Among Over-weight or Obese Women Who Are Undergoing Elective Caesarean Section

Overweight or Obese Women, Elective Lower Segment Cesarean Section
Eli Lilly and Company

Completed

A Study of LY3016859 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Ain Shams University

Completed

Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients

Abdominal Delivery
University Medical Center Groningen
Radboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaborators

Recruiting

Reduced Anticoagulation Targets in ECLS (RATE) (RATE)

Heart Failure | Thrombosis | Respiratory Failure | Bleeding | Extracorporeal Membrane Oxygenation

Netherlands
AlRefaey Kandeel

Completed

Subcutaneous NTG for US Radial Artery Cannulation (NTG-US-art)

Morbid Obesity

Search clinical trials for: Subcutaneous enoxaparin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations